Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes

Vaccine. 2008 May 23;26(22):2796-806. doi: 10.1016/j.vaccine.2007.11.083. Epub 2007 Dec 26.

Abstract

In this study, immunizations at 2 weeks vs. 6 weeks intervals, with an HIV-1 envelope protein in adjuvants, through intra-nasal (IN), intra-muscular (IM), IN followed by IM (IN/IM) and IM/IN, were compared for induction of mucosal and systemic immune responses. IN/IM immunizations at 2, but not at 6, week intervals induced the highest mucosal and systemic immune responses compared to other immunization routes. Following a resting memory phase, IN boosting of IN/IM-immunized mice, compared to IM-boosting of IM-immunized mice, induced increased IgA responses. Thus, depending on the immunization intervals, IN/IM may be more effective than IM immunizations for short- and long-term immunity.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Vaccines / administration & dosage*
  • AIDS Vaccines / genetics
  • AIDS Vaccines / immunology*
  • Administration, Intranasal
  • Animals
  • Cytokines / biosynthesis
  • Female
  • HIV Antibodies / analysis
  • HIV Envelope Protein gp160 / administration & dosage*
  • HIV Envelope Protein gp160 / genetics
  • HIV Envelope Protein gp160 / immunology*
  • Immunity, Mucosal*
  • Immunization, Secondary
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Immunologic Memory*
  • Injections, Intramuscular
  • Mice
  • Mice, Inbred BALB C
  • T-Lymphocytes / immunology
  • Time Factors

Substances

  • AIDS Vaccines
  • Cytokines
  • HIV Antibodies
  • HIV Envelope Protein gp160
  • Immunoglobulin A
  • Immunoglobulin G